Resistance training and protein: the sarcopenia floor
Before peptides, supplements, or any longevity protocol — there is a floor. Most of it costs nothing.
TL;DR
- Sarcopenia (age-related muscle loss) is the strongest single predictor of late-life functional decline.
- The floor is two things: resistance training 2 to 3 times per week, and 1.0 to 1.2 grams of protein per kilogram of body weight daily.
- Most peptide protocols build on this floor. Skipping the floor wastes everything above it.
What it is
Sarcopenia (in plain English: the gradual loss of muscle mass and strength that starts in the 30s and accelerates after 60) is the structural problem behind most loss of independence in older adults. Healthy adults lose about 3 to 8 percent of muscle mass per decade after 30. Without resistance training, that number doubles after 60. Think of muscle like a savings account. You spend a little every year. Without deposits, the balance gets dangerously low at exactly the moment you need it most.
How it works
Muscle is in constant turnover — built up through muscle protein synthesis and broken down through muscle protein breakdown. Two signals trigger the synthesis side. One is mechanical: a muscle has to be loaded against resistance. The other is nutritional: enough amino acids — especially leucine — have to be available in the blood. With age, the body becomes less responsive to both signals (called “anabolic resistance”), so older adults need more of each to produce the same response, per Bauer et al., PROT-AGE 2014.
Who asks about it
People come to this topic when they notice a decline they cannot explain. Slower walking pace. Trouble carrying groceries. A fall they would not have had at 40. The conversation often starts with frustration and ends with a simple two-part prescription. About 4 in 10 adults over 70 meet the clinical criteria for sarcopenia.
What the research says
The Society on Sarcopenia, Cachexia and Wasting Disorders has published explicit nutrition guidance for adults over 50. Resistance training 2 to 3 times weekly combined with 1.0 to 1.2 g/kg protein daily reverses or slows sarcopenia in most controlled trials, per Deutz et al. 2018. The trial designs use simple interventions: bands, body-weight, or basic weight machines. Specialized equipment is not required.
What to know before considering it
Anyone with kidney disease needs to discuss protein intake with their clinician — the higher targets are not appropriate for everyone. Resistance training should start with form, not load. A licensed trainer, physical therapist, or simple progression through body-weight movements works for most starting points. Joint pain is not a reason to skip — it is usually a reason to scale.
The Halftime POV
The sarcopenia floor matters more than any peptide we offer. Without resistance training and adequate protein, growth-hormone peptides and GLP-1s both lose meaningful effect — one builds nothing without the load, the other accelerates muscle loss without the floor. We talk about this on every initial consult.
Related reading:
- DEXA body composition: what the scan measures
- The protein-first protocol for GLP-1 patients
- Peptides and Alzheimer’s: the emerging literature
Disclaimer
This article is educational and is not medical advice. Compounded medications are not FDA-approved. Clinical outcomes depend on individual factors and require physician evaluation. Results vary. Halftime Health is launching soon — join the waitlist to get updates.
Get updates
Halftime Health is launching soon. We’ll share what we learn along the way — the research, the regulations, the real-world trade-offs. Join the waitlist and we’ll email you when we’re live.
Sources
- Bauer et al. — PROT-AGE Study Group, 2014
- Deutz et al. — Protein intake and exercise for optimal muscle, 2018
Sources & references
- pubmed.ncbi.nlm.nih.gov — https://pubmed.ncbi.nlm.nih.gov/24814383/
- pubmed.ncbi.nlm.nih.gov — https://pubmed.ncbi.nlm.nih.gov/29945240/